Xueming Wu

Department of Biomedical Engineering, Case Western Reserve University

Affiliated withCase Western Reserve University

Research Area

Biography

Xueming Wu has not added Biography.
If you are Xueming Wu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2013

Other Publications

Article	Year
The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine. Drug development and industrial pharmacy\| PubMed ID: 15285336	2004
A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI. Bioconjugate chemistry\| PubMed ID: 19053180	2008
Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice. Molecular pharmaceutics\| PubMed ID: 19296675	2009
Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice. Pharmaceutical research\| PubMed ID: 19597972	2009
Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers. Molecular pharmaceutics\| PubMed ID: 19958031	2010
Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging. Biomacromolecules\| PubMed ID: 20131758	2010
Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats. Pharmaceutical research\| PubMed ID: 20393871	2010
An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix. Molecular pharmaceutics\| PubMed ID: 20481565	2010
Polydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents. Israel journal of chemistry\| PubMed ID: 21331318	2010
Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents. Bioconjugate chemistry\| PubMed ID: 21473650	2011
Ocular pharmacokinetic study using Tâ‚ mapping and Gd-chelate- labeled polymers. Pharmaceutical research\| PubMed ID: 21691891	2011
Polydisulfide manganese(II) complexes as non-gadolinium biodegradable macromolecular MRI contrast agents. Journal of magnetic resonance imaging : JMRI\| PubMed ID: 22031457	2012
MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model. Pharmaceutical research\| PubMed ID: 22139536	2012
Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer. Bioconjugate chemistry\| PubMed ID: 22812444	2012
An efficient novel glycosylation of flavonoid by Î²-fructosidase resistant to hydrophilic organic solvents. Bioresource technology\| PubMed ID: 23298773	2013
Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging. Contrast media & molecular imaging\| PubMed ID: 23606425	2013
Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI. Biomaterials\| PubMed ID: 23863450	2013
Isolation, identification and pharmacokinetic analysis of fructosyl puerarins from enzymatic glycosylation. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences\| PubMed ID: 23948238	2013